Aug 2016
pharming
Financial Adviser
USD 125 million
Acquisition of the North American rights to RUCONEST

Pharming

Pharming is a public biotech company developing innovative products for the treatment of unmet medical needs

  • Conwert, listed in Vienna, has a € 2.7 billion real estate portfolio mainly comprising residential real estate in attractive cities including Leipzig, Berlin, Potsdam, Vienna and Dresden.
  • The transaction marks the largest successful public European real estate transaction in 2016.
  • Kempen & Co acted as Sole M&A adviser in the transaction.